Zimbabwe has rejected a major American health deal worth $367m (£272m) spanning five years due to the United States' request for sensitive biological samples.
This move was revealed after a official document dated December was disclosed, which showed President Emmerson Mnangagwa believed the arrangement was "skewed".
A government spokesman has since clarified that the US was requesting biological samples for research and commercial purposes but refused to share the benefits from any future treatments.
"We must now begin the difficult and regrettable task of ending our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy said the US had donated more than $1.9bn as health assistance to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has called for more talks to secure a deal agreeable to both sides so the country's critical HIV programme can be sustained.
Broader Background
Zimbabwe's decision comes after a similar case in Kenya, where a high court halted a related health funding agreement after concerns were raised about the security of Kenyans' health data.
Since returning to office recently, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.
The agency had managed assistance for the US government, but Trump stated its expenditure was "inefficient" and his administration was pursuing government-to-government agreements to enhance transparency and responsibility.
According to statements, Sixteen nations in Africa have to date agreed to similar agreements, constituting over $18.3bn in committed funds.
Details of the Declined Agreement
The funds for Zimbabwe was intended to gone towards "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We are confident this collaboration would have delivered significant benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on antiretroviral therapy through US-supported programmes," the Ambassador said.
However, official spokesman Nick Mangwana said the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to provide its genetic material and health information for a long time, without any corresponding guarantee of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that might result from that shared data," his statement read.
"Effectively, our nation would provide the raw materials for medical research with no assurance that the resulting innovations would be accessible to our citizens should a future pandemic arise."
Sovereignty and International Frameworks
Mangwana further noted that the American exit from the World Health Organization (WHO) and its push of bilateral deals were disrupting structures already set up through the international organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework designed to deal with potential pandemics.
"This mechanism is designed to guarantee that when a nation provides its data, the benefits – such as vaccines and treatments – are distributed fairly, not monopolised solely by those with the capability to develop them."
The government's concerns regarding the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We welcome continued dialogue with our US partners on how subsequent co-operation might be designed in a manner that honours the sovereignty and dignity of each country."
Medical Community Reaction
Medical experts expressed it recognised the government's concerns, but recommended that negotiations should continue since a large portion of the nation's HIV programmes depended on external financing.
"In cases where specific concerns arise, including those relating to information security or agreement terms, these can often be resolved through technical clarification and mutually agreed protections," the group commented.
This impasse highlights the complex debate between receiving much-needed international aid and safeguarding local interests in an ever more interconnected world.